comparemela.com

Latest Breaking News On - Bryan campbell - Page 7 : comparemela.com

FDA Approves Ide-Cel for Triple-Class Exposed R/R Multiple Myeloma

The FDA has approved ide-cel (Abecma) for adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy.

FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy

vimarsana © 2020. All Rights Reserved.